Ganglioside GM1 sensitizes tumor cells to growth inhibitory glycopeptides.
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002518:Ceramides / Q000494:pharmacology; D002540:Cerebral Cortex / Q000032:analysis*; D004357:Drug Synergism; D005354:Fibrosarcoma / Q000378:metabolism*; D005677:G(M1) Ganglioside / Q000494:pharmacology*; D005732:Gangliosides / Q000494:pharmacology*; D006020:Glycopeptides / Q000302:isolation & purification / Q000494:pharmacology*; D051379:Mice; D014176:Protein Biosynthesis / Q000187:drug effects
D002518:Ceramides; D005732:Gangliosides; D006020:Glycopeptides; D005677:G(M1) Ganglioside